Clinical Trials Browser

Completed × ALK Gene Rearrangement Positive × Bevacizumab × Clear all

NCT03779191 2023-07-06

Alectinib in Combination With Bevacizumab in ALK Positive NSCLC

Phase 2 Completed

ALK Gene Rearrangement Positive